Search Results 581-590 of 13510 for monoclonal antibody

  1. Dinutuximab (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is a GD2-binding monoclonal antibody. This medicine is to be given only by or under the direct supervision of your doctor. This product is ...

  2. A Study To Compare Three Chemotherapy Regimens For The Treatment Of Patients With Newly- Diagnosed Mantle Cell Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Acalabrutinib may stop the growth of cancer ...

  3. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Monoclonal antibodies help COVID-19 patients avoid hospitalization featured image · Strong immune response underlies acute kidney injury related ...

  4. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  5. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody treatment can help high-risk ...

  6. Soft Tissue Sarcoma Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  7. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  8. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  9. Penpulimab-kcqx (intravenous route) - Side effects & uses - Mayo Clinic

    Penpulimab-kcqx is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

  10. Teclistamab-cqyv (subcutaneous route) - Side effects & uses - Mayo Clinic

    These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...